Page last updated: 2024-12-05

chloroacetonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7856
CHEMBL ID3187297
CHEBI ID82416
MeSH IDM0189128

Synonyms (64)

Synonym
2-chloro-acetonitrile
monochloroacetonitrile
.alpha.-chloroacetonitrile
wln: nc1g
chloracetonitrile
usaf kf-5
chloromethyl cyanide
monochloromethyl cyanide
acetonitrile, chloro-
nsc6180
chloroethanenitrile
2-chloroacetonitrile
chloroacetonitrile
nsc-6180
107-14-2
acetic acid,chloro,nitrile
inchi=1/c2h2cln/c3-1-2-4/h1h
hsdb 6317
alpha-chloroacetonitrile
un2668
brn 0506028
nsc 6180
ai3-52205
einecs 203-467-0
ccris 2670
chloroacetonitrile, 99%
AKOS000118818
NCGC00248886-01
cn524k9dxd ,
acetonitrile, 2-chloro-
4-02-00-00492 (beilstein handbook reference)
unii-cn524k9dxd
chloroacetonitrile [un2668] [poison]
chloro-acetonitrile
C19360
dtxsid7021524 ,
tox21_200957
cas-107-14-2
dtxcid301524
NCGC00258510-01
FT-0623631
chloroacetonitrile [iarc]
chloroacetonitrile [hsdb]
CHEBI:82416 ,
c2h2cln
chloro acetonitrile
clch2cn
cyanomethyl chloride
2chloroacetonitrile
chloroactonitrile
chloroaceto nitrile
2-cloroacetonitrile
un 2668
ch2clcn
CHEMBL3187297
mfcd00001885
J-509002
F2190-0287
chloroacetonitrile, purum, >=99.0% (gc)
Q2196683
BCP27602
STL185582
chloroethane nitrile
EN300-19495

Research Excerpts

Overview

Chloroacetonitrile (CAN) is a disinfection by-product of chlorination of drinking water. It is considered as a direct-acting mutagenic and carcinogenic agent.

ExcerptReferenceRelevance
"Chloroacetonitrile (CAN) is a halogenated acetonitrile often produced while disinfecting drinking water. "( Chloroacetonitrile exposure induces endoplasmic reticulum stress and affects spindle assembly in mouse oocytes.
Chen, YZ; Liu, Y; Liu, YC; Qi, ZQ; Qiao, FX; Sun, MX; Wang, HL; Xu, CL; Xu, ZR, 2023
)
3.8
"Chloroacetonitrile (CAN) is a by-product of chlorination of drinking water. "( Chloroacetonitrile induces intrauterine growth restriction and musculoskeletal toxicity in fetal mouse.
Abdel-Naim, AB; Ahmed, AE; El-Mazar, HM; Nagy, AA, 2008
)
3.23
"Chloroacetonitrile (CAN) is a disinfection by-product of chlorination of drinking water. "( Chloroacetonitrile induces oxidative stress and apoptosis in mouse fetal liver.
Abdel-Naim, AB; Ahmed, AE; El-Mazar, HM; Mohamadin, AM; Nagy, AA, 2009
)
3.24
"Chloroacetonitrile is a disinfectant by-product of chlorination of drinking water and is considered as a direct-acting mutagenic and carcinogenic agent. "( Mechanisms of hepatotoxicity of chloroacetonitrile - an end product of water chlorination.
Abo-Salem, OM; Al-Zahrani, SS; Ghonaim, MM, 2013
)
2.12
"Chloroacetonitrile (CAN) is a disinfection by-product of chlorination of drinking water. "( Myeloperoxidase-catalyzed oxidation of chloroacetonitrile to cyanide.
Abdel-Naim, AB; Mohamadin, AM, 2004
)
2.04
"Chloroacetonitrile (CAN), is a disinfectant by-product of chlorination of drinking water. "( Chloroacetonitrile-induced toxicity and oxidative stress in rat gastric epithelial cells.
Abdel-Naim, AB; Mohamadin, AM, 1999
)
3.19

Toxicity

ExcerptReferenceRelevance
" These toxic responses to CAN were dependent on both concentration and duration of exposure to CAN."( Chloroacetonitrile-induced toxicity and oxidative stress in rat gastric epithelial cells.
Abdel-Naim, AB; Mohamadin, AM, 1999
)
1.75
" The present study was designed to investigate the potential adverse effects of intrauterine exposure to CAN on fetal body weight and development of the musculoskeletal system in mice."( Chloroacetonitrile induces intrauterine growth restriction and musculoskeletal toxicity in fetal mouse.
Abdel-Naim, AB; Ahmed, AE; El-Mazar, HM; Nagy, AA, 2008
)
1.79
"The concept of multiple modes of toxic action denotes that an individual chemical can induce two or more toxic effects within the same series of concentrations, for example, reactive toxicity and narcosis."( Mixture toxicity of SN2-reactive soft electrophiles: 1. Evaluation of mixtures containing α-halogenated acetonitriles.
Dawson, DA; Jeyaratnam, J; Mooneyham, T; Pöch, G; Schultz, TW, 2010
)
0.36
" It is possible that HAN disruption of the normal cell cycle and the generation of aberrant cells with an abnormal number of chromosomes may contribute to cancer induction and perhaps be involved in the induction of adverse pregnancy outcomes associated with long-term consumption of disinfected water."( Toxicity of drinking water disinfection byproducts: cell cycle alterations induced by the monohaloacetonitriles.
Komaki, Y; Mariñas, BJ; Plewa, MJ, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Based on an initial dose-response experiment, CAN (25mg/(kgday)) was given orally to pregnant mice at gestation day (GD) 6, till GD 18."( Chloroacetonitrile induces oxidative stress and apoptosis in mouse fetal liver.
Abdel-Naim, AB; Ahmed, AE; El-Mazar, HM; Mohamadin, AM; Nagy, AA, 2009
)
1.8
" Time-course and dose-response studies were performed to examine the mechanism of chloroacetonitrile-induced hepatotoxicity."( Mechanisms of hepatotoxicity of chloroacetonitrile - an end product of water chlorination.
Abo-Salem, OM; Al-Zahrani, SS; Ghonaim, MM, 2013
)
0.9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency12.70750.000221.22318,912.5098AID1259243
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency56.76210.001022.650876.6163AID1224838
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency52.76670.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency56.76210.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency33.37040.000229.305416,493.5996AID1259244; AID743075; AID743079
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency71.45930.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency71.45930.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (23.81)18.2507
2000's9 (42.86)29.6817
2010's6 (28.57)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.98 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index53.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]